Cheng Luo

19.3k citations
470 papers · 14.0k · 4 hit papers · h-index 54

Impact in

    • Epigenetics and DNA Methylation
    • RNA modifications and cancer
    • Cancer-related gene regulation
    • Sphingolipid Metabolism and Signaling
    • Protein Degradation and Inhibitors
    • Histone Deacetylase Inhibitors Research
    • Cancer-related molecular mechanisms research

Papers in

    • Epigenetics and DNA Methylation 66
    • Protein Degradation and Inhibitors 52
    • Cancer-related gene regulation 52
    • Ubiquitin and proteasome pathways 37
    • Histone Deacetylase Inhibitors Research 26
    • RNA modifications and cancer 25

Cheng Luo

456 papers receiving 13.8k citations

Cheng Luo's Hit Papers

Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1 2023 · 127 citations
1270+5+11Years since publication250500750

Peers

Cheng Luo
Comparison fields: 5 of 190
  • Molecular Biology 8.8k
  • Cancer Research 1.3k
  • Computational Theory and Mathematics 1.0k
  • Oncology 1.3k
  • Organic Chemistry 1.5k
Replace Honglin Li with:
Honglin Li China
Wei Zheng United States
Robert A. Copeland United States
Xiang Chen China
Md. Imtaiyaz Hassan India
Manuel C. Peitsch Switzerland
Anton Simeonov United States
Christopher P. Austin United States
Paul A. Clemons United States
Duxin Sun United States
Cheng Luo relative to Honglin Li China Honglin Li's profile →
Citations per field
00.5×1.5×
Honglin Li · 1×
Citations per year

Countries citing papers authored by Cheng Luo

Since Specialization
Citations

This map shows the geographic impact of Cheng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Luo more than expected).

Fields of papers citing papers by Cheng Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Luo. The network helps show where Cheng Luo may publish in the future.

Co-authors

The 25 scholars most cited alongside Cheng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheng Luo Line = papers co-authored together Cheng Luo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 470 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate
Hit paper breakdown →
2009835
2
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
Hit paper breakdown →
2010632
3
Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5
Hit paper breakdown →
2014570
4 2012395
5 2015290
6 2012265
7 2012264
8 2006235
9 2015187
10 2014181
11 2014175
12 2017172
13 2012149
14 2021144
15 2014141
16
Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1
Hit paper breakdown →
2023127
17 2017127
18 2012115
19 2017115
20 2020114

About Cheng Luo

Cheng Luo is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cancer Research and Immunology, having authored 470 papers that have together received 14.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (66 papers), Protein Degradation and Inhibitors (52 papers), Cancer-related gene regulation (52 papers), Ubiquitin and proteasome pathways (37 papers), Histone Deacetylase Inhibitors Research (26 papers), Computational Drug Discovery Methods (25 papers), RNA modifications and cancer (25 papers) and Multiple Myeloma Research and Treatments (20 papers). The work is most often cited by research in Molecular Biology (8.8k citations), Cancer Research (1.3k citations), Computational Theory and Mathematics (1.0k citations), Oncology (1.3k citations) and Organic Chemistry (1.5k citations). Cheng Luo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hualiang Jiang, Kaixian Chen, Zhongjie Liang, Nitai C. Hait, Sarah Spiegel, Jeremy C. Allegood, Junyan Lu, Sheldon Milstien, Tomasz Kordula and Kuzhuvelil B. Harikumar. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, PLoS ONE and Bioorganic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact